Homoisoflavonoids: Natural Scaffolds with Potent and Selective Monoamine Oxidase-B Inhibition Properties
Citations Over TimeTop 10% of 2011 papers
Abstract
A series of homoisoflavonoids [(E)-3-benzylidenechroman-4-ones 1a-w, 3-benzyl-4H-chromen-4-ones 2a-g, and 3-benzylchroman-4-ones 3a-e] have been synthesized and tested in vitro as inhibitors of human monoamine oxidase isoforms A and B (hMAO-A and hMAO-B). Most of the compounds were found to be potent and selective MAO-B inhibitors. In general, the (E)-3-benzylidenechroman-4-ones 1a-w showed activities in the nano- or micromolar range coupled with high selectivity against hMAO-B. The reduction of the exocyclic double bond results in compounds 3a-e selective against isoform B and active in the micromolar range. In contrast, the endocyclic migration of the double bond (compounds 2a-g) generally produces the loss of the inhibitory activity or a marked reduction in potency. (E)-3-(4-(Dimethylamino)benzylidene)chroman-4-one (1l) and (E)-5,7-dihydroxy-3-(4-hydroxybenzylidene)chroman-4-one (1h) were the most interesting compounds of the entire series of inhibitors, showing hMAO-B affinity better than the selective inhibitor selegiline. Molecular modeling studies have been carried out to explain the selectivity of the most active homoisoflavonoids 1h and 1l.
Related Papers
- → Increased monoamine oxidase messenger RNA expression levels in frontal cortex of Alzheimer's disease patients(2002)98 cited
- → Deamination of 5‐Hydroxytryptamine by Both Forms of Monoamine Oxidase in the Rat Brain(1982)126 cited
- → Monoamine oxidase inhibitors and their pharmacological significance(1983)3 cited
- Docking of Novel Reversible Monoamine Oxidase-B Inhibitors and their Antiparkinsonian Effect(2017)
- → Inhibition of Monoamine Oxidases (MAOs) by Green Tea Extracts(2018)